The Sperm Chromatin Structure Assay As a Diagnostic Tool in the Human Fertility Clinic
Overview
Affiliations
Background: Sperm DNA integrity has been shown to be necessary for achieving and sustaining embryo development. The objective was to evaluate the sperm chromatin structure assay (SCSA) as a diagnostic tool in clinical practice for intrauterine insemination (IUI), in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatments.
Methods: A total of 385 semen samples from 234 couples were frozen for SCSA, and smears were prepared for morphology: 48 IUI, 139 IVF and 47 ICSI. The main SCSA variables were DNA fragmentation index (DFI), standard deviation of DFI (SD-DFI) and high DNA stainability (HDS), and the reproductive outcomes were biochemical pregnancy (BP), clinical pregnancy (CP) and implantation ratio (IR).
Results: The results showed no significant difference in the fertility variables BP, CP and IR when <27% DFI was used between the IVF and ICSI groups. A low number of patients received IUI with low success rate, and statistical analysis was therefore not performed. Ongoing pregnancy was achieved for both IVF and ICSI couples with DFI levels >27%, and six couples in ICSI treatment achieved CP full-term. DFI >27% had a high prognostic power for predicting no CP for IVF patients, with a specificity of 97%. Couples diagnosed with male infertility had a significantly higher level of DFI compared to couples with idiopathic fertility. Sperm head morphology showed low but significant correlations with the SCSA variables.
Conclusion: SCSA is a useful tool in andrological diagnosis and contributes with a prognosis for the fertility outcome of conventional IVF. Although full-term pregnancy can be achieved with assisted reproductive techniques with a DFI >27%, the probability of a successful pregnancy may be reduced.
Sabbaghian M, Hosseinifar H, Rafaee A, Sadighi Gilani M J Hum Reprod Sci. 2023; 15(4):377-381.
PMID: 37033135 PMC: 10077746. DOI: 10.4103/jhrs.jhrs_145_22.
New horizons in human sperm selection for assisted reproduction.
Nixon B, Schjenken J, Burke N, Skerrett-Byrne D, Hart H, De Iuliis G Front Endocrinol (Lausanne). 2023; 14:1145533.
PMID: 36909306 PMC: 9992892. DOI: 10.3389/fendo.2023.1145533.
Tvrda E, duracka M, Benko F, Kovacik A, Lovisek D, Galova E Int J Mol Sci. 2023; 24(4).
PMID: 36834909 PMC: 9963725. DOI: 10.3390/ijms24043503.
The Association of Sperm DNA Fragment and Assisted Reproductive Outcomes: A Meta-Analysis.
Chen Y, Li W, Chen X Comput Math Methods Med. 2022; 2022:1126616.
PMID: 36158125 PMC: 9492328. DOI: 10.1155/2022/1126616.
Zhu C, Chen F, Zhang S, She H, Ju Y, Wen X Front Endocrinol (Lausanne). 2022; 13:945242.
PMID: 35909570 PMC: 9329669. DOI: 10.3389/fendo.2022.945242.